Circulation

MARCH 11, 2024

BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Patients were categorized by diabetes status. PintHR=0.87) diabetes.

Coronary Artery Bypass Graft 81

Coronary Artery Bypass Graft Diabetes Coronary Artery Disease Stents 81

Dr. Paddy Barrett

APRIL 26, 2024

Coronary artery disease is caused by the retention of a cholesterol particle in the artery wall. On the far end of that line is type two diabetes. On the far end of that line is type two diabetes. We also know that WHEN you get type 2 diabetes makes a huge difference. Let me be 100% clear, however.

Heart Disease 95

Heart Disease Coronary Artery Disease Diabetes Genetic predisposition 95

Coronary Artery Disease Journal

NOVEMBER 20, 2023

Background: Gender-specific outcomes after percutaneous coronary interventions were studied by a number of research groups with different endpoints and cohorts of different ethnic extractions. Results: Overall, in the unmatched cohorts, accumulated target-lesion revascularization rates did not differ between both genders (2.7%

Stents 52

Stents Stent Outcomes Coronary Artery Disease 52

Open Heart

JUNE 5, 2024

Background There is increasing awareness that patients without standard modifiable risk factors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). Patients with coronary artery disease were excluded.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

Cardiometabolic Health Congress

NOVEMBER 22, 2024

Diabetes and Obesity Care Advancements New Technologies for Diabetes Management : The recent FDA approvals of various insulin delivery devices, including the Embecta patch pump for Type 2 diabetes , have expanded patient options. New developments in continuous glucose monitors (CGMs) have also been transformative.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. 23), which was not associated with better/worse clinical outcomes in patients with prior CABG.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40

DAIC

APRIL 9, 2024

The international ARISE-HF trial was designed to test the effectiveness of the investigational drug AT-001 at stabilizing exercise capacity in patients with diabetic cardiomyopathy. Patients had had Type 2 diabetes for an average of 14 years. Decline in exercise ability is a hallmark of progression to overt heart failure.

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThere is a higher prevalence of diabetes mellitus type 2 in Hispanics as compared to other ethnic groups in the United States. Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. or greater. vs. 20.5%; p = 0.048) and stenting (28.4%

Outcomes 40

Outcomes Angioplasty Atrial Fibrillation Diabetes 40

Dr. Paddy Barrett

APRIL 5, 2024

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

Heart Disease 106

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 106

Stroke Journal

FEBRUARY 1, 2024

Malnutrition is common in stroke patients and leads to worse outcomes. Body mass index (BMI) is a widely available marker of nutrition status, however studies on BMI and post-ICH outcomes are limited and have conflicting results. There was no association between BMI and ICH volume in patients with deep or lobar hemorrhage.

Hemorrhage 40

Hemorrhage BMI Outcomes Coronary Artery Disease 40

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

Introduction The presence of non-coronary atherosclerosis (NCA) in patients with coronary artery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronary artery bypass grafting (CABG). vs. 9%, p  < 0.001).

Coronary Artery Bypass Graft 64

Coronary Artery Bypass Graft Atherosclerosis Peripheral Arterial Disease Coronary Artery Disease 64

The British Journal of Cardiology

APRIL 16, 2024

We present the cumulative percutaneous coronary intervention (PCI) data of all comers (stable angina and acute coronary syndromes [ACS]) who presented to Hadi Clinic between January 2018 and December 2020. A total of 567 patients underwent coronary catheterisation for the three-year period between January 2018 and December 2020.

Outcomes 52

Outcomes Cardiogenic Shock Angina STEMI 52

Circulation

NOVEMBER 11, 2024

The outcome measure was peri-procedural complications defined as a composite of perioperative death, major bleeding, contrast nephropathy, myocardial infarction, ischemic stroke, and major amputation. Notable comorbidities included diabetes mellitus at 60.6% A history of coronary artery disease was noted in 40.7%

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Disease Ischemia Stroke 40

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction The use of contemporary drug-eluting stents (DES) has significantly improved outcomes of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). years, Diabetes mellitus 29%, acute coronary syndrome 67%, chronic total occlusion 9%).

Stents 64

Stents Stent Cardiogenic Shock Coronary Artery Disease 64

Stroke Journal

FEBRUARY 1, 2024

Studies have reported racial disparities in young stroke patients and less desired outcomes of minorities. Socioeconomic status, risk factors, stroke etiology, acute interventions and short-term outcomes were accessed. Compared to White, black and Hispanic had higher rate of Diabetes, Hypertension and prior stroke (p&lt;0.001).

Stroke 40

Stroke Strokes Coronary Artery Disease Risk Factors 40

Coronary Artery Disease Journal

JANUARY 11, 2024

Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. Previous studies showed considerable risks of outcomes in this group. In this study, we aimed to investigate the long-term outcomes in very young patients with MINOCA.

Myocardial Infarction 40

Myocardial Infarction Outcomes Atrial Fibrillation Risk Factors 40

Dr. Paddy Barrett

OCTOBER 11, 2024

Inflammation is a key driver of heart disease, specifically coronary artery disease. I have covered this topic previously here , but it is clear that inflammation plays a major role in the initiation and progression of coronary artery disease, and the inflammatory biomarker hsCRP is tightly connected to this process.

Obesity 61

Obesity Dementia Cancer Coronary Artery Disease 61

European Journal of Heart Failure

SEPTEMBER 26, 2023

diabetes, hypertension, coronary artery disease), underlying the development of cardiac dysfunction and further increased risk. Overall, understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes and reducing healthcare costs.

Heart Failure 40

Heart Failure Coronary Artery Disease Outpatient Document 40

Stroke Journal

DECEMBER 8, 2023

The primary outcome was ischemic stroke; the secondary outcome was combined cardiovascular events (ischemic stroke, myocardial infarction, and cardiovascular death). The plaque-related risk of outcomes was also analyzed according to the presence of statin treatment.

Plaque 40

Plaque Aortic Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

We compared demographics, hospital traits, comorbidities, and outcomes. In-hospital mortality, our primary outcome, was analyzed through multivariate logistic regression using STATA 18.Results:Incorporating to 2.26) and liver disease (OR 2.20, p &lt; 0.01, CI 1.27

Inpatient 40

Inpatient Stroke Strokes Coronary Artery Disease 40

Cardiology Update

APRIL 9, 2024

The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure. The percent change from baseline in fasting TG at six months served as the primary outcome measure. Among patients with HFpEF, those who received the shunt experienced poor outcomes than those who did not.

Myocardial Infarction 52

Myocardial Infarction Angina Aortic valve Coronary Artery Disease 52

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

European Journal of Heart Failure

SEPTEMBER 15, 2023

A prior history of the following comorbidities was considered: episodic or persistent atrial fibrillation ( n  = 920), coronary artery disease ( n  = 3732), diabetes ( n  = 2171), and hypertension ( n  = 3353). Patients were classified into three groups based on the number of comorbidities: 0, 1–2, or ≥3.

Coronary Artery Disease 40

Coronary Artery Disease Heart Failure Atrial Fibrillation Outcomes 40

Dr. Paddy Barrett

OCTOBER 31, 2023

An elevated Lp(a) is a common genetic factor that is independently and causally related to premature coronary artery disease. The occurrence of disease in this instance is probabilistic, not deterministic. An elevated Lp(a) does increase the risk of early cardiovascular disease, but that risk is not set in stone.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Outcomes of interest included symptomatic intracerebral hemorrhage (ICH), asymptomatic ICH, hemorrhagic transformation, mass effect and death. Median LDL was higher (94 vs 67, p=0.01) and there was a higher rate of diabetes (55.2% Baseline demographics and clinical characteristics were compared. vs 26.6%, p=0.01).

Thrombolysis 40

Thrombolysis Angioplasty Hemorrhage Stents 40

Dr. Anish Koka

MAY 16, 2023

Soviet biologist Trofim Lysenko famously rejected the objective reality of Mendelian genetics because it clashed with the Marxist philosophy that the environment, not genetics, was the primary determinant of outcomes. This particular passage references the fact women and men commonly complain of chest pain.

Chest Pain 52

Chest Pain Coronary Artery Disease Cancer Heart Attack 52

DAIC

MARCH 13, 2024

Smith Center for Outcomes Research in Cardiology and section chief of Interventional Cardiology at BIDMC. Even with advances in stent technology, patients with coronary in-stent restenosis continue to comprise approximately 10 percent of individuals undergoing angioplasty interventions each year. and Susan F.

Angioplasty 116

Angioplasty Stents Stent Myocardial Infarction 116

Cardiometabolic Health Congress

AUGUST 2, 2024

Blood Sugar Management: For individuals with or at risk of diabetes, precision nutrition offers tailored strategies to manage blood glucose levels by identifying individual responses to different foods. This is particularly beneficial in managing conditions like hypertension, where precise control of dietary sodium intake is crucial.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

Circulation

NOVEMBER 11, 2024

All patients were prospectively followed for development of new outcome/cardiac events which included hospitalization for acute HF, CVS-related death, heart transplantation, and also diabetic complications. Circulation, Volume 150, Issue Suppl_1 , Page A4138589-A4138589, November 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Heart Transplant Tricuspid 40

Cardiometabolic Health Congress

JULY 25, 2023

Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1]

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Open Heart

MAY 12, 2023

Objective Antithrombotic therapy is essential for patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) because of the high risk of thrombosis, whereas a combination of antiplatelets and anticoagulants is associated with a high risk of bleeding.

Coronary Artery Disease 52

Coronary Artery Disease Atrial Fibrillation Myocardial Infarction Blood Pressure 52

Dr. Smith's ECG Blog

SEPTEMBER 25, 2024

A 56 year old male with a history of diabetes, dyslipidemia, hypertension, and coronary artery disease presented to the emergency department with sudden onset weakness, fatigue, lethargy, and confusion. This is another case sent by the undergraduate (who is applying to med school) who works as an EKG tech.

Chest Pain 111

Chest Pain Blog Hospital Tachycardia 111

Dr. Paddy Barrett

MAY 17, 2024

Regardless of what is driving the effect, it is clear that experiencing high levels of stress is associated with worse outcomes. 24% increased risk of coronary artery disease. While studies attempt to correct for these influences, it can be very hard to do. These findings have been replicated multiple times.

Heart Disease 88

Heart Disease Heart Attack Heart attacks Risk Factors 88

EMS 12-Lead

MARCH 19, 2023

He denied any known medical history, specifically: coronary artery disease, hypertension, dyslipidemia, diabetes, heart failure, myocardial infarction, or any prior PCI/stent. Vital signs were noted to be unremarkable with respect to any hypo-hypertensive crisis, hypoxia, etc. Breath sounds were clear in all lung fields.

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Angiogram Coronary Artery Disease 52

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

They concluded that early rhythm control therapy was associated with a lower risk of adverse cardiovascular outcomes than usual care among patients with early atrial fibrillation and cardiovascular conditions. The study was stopped for efficacy at the third interim analysis after a median of 5.1 years of follow up per patient.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

Circulation

NOVEMBER 11, 2024

However, the observed incongruity between carotid disease and the presence and severity of coronary artery disease (CAD) suggests differing mechanisms. The incidence of the combined outcome showed a progressive increase with higher VasD scores (p&lt;0.001). Subsequently, patients were followed for 5.5

Exercise 40

Exercise Coronary Artery Disease Ultrasound Atherosclerosis 40